NCT00802919 |
|
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
|
View
|
NCT01165996 |
|
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
|
View
|
NCT04851834 |
|
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
|
View
|
NCT05042531 |
|
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
|
View
|
NCT04167917 |
|
NTX-301 in MDSAML
|
View
|
NCT05960773 |
|
DecitabineCedazuridine INQOVI an Oral DNA Demethylating Agent in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical Early-Stage Mesothelioma
|
View
|
NCT06102629 |
|
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy
|
View
|
NCT02564536 |
|
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm MPNMyelodysplastic Syndrome MDS
|
View
|
NCT02664181 |
|
Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC PRECISE Trial
|
View
|